The international airport for the Hunter will open next year and is projected to generate 4,400 full time jobs and deliver $12.7 billion into the regional economy.

Two University of Newcastle researchers will focus on one of the world’s most insidious diseases – cancer, supported by more than $3.9m in National Health and Medical Research Council (NHMRC) Investigator grants.

The NUW Alliance - a grouping of four leading Australian universities, The University of Newcastle, the University of Wollongong, UNSW Sydney and Western Sydney University – launches its Six Cities Region Vision featuring 3 pillars of focus – Sustainability, Infrastructure and Women.

The Australian Research Council (ARC) has announced its latest round of funding for Linkage Project grants, with two University of Newcastle projects attracting funding totalling nearly $800,000.

The University of Newcastle will put innovators, problem solvers, tech heads and designers to the test at the New Futures Hackathon for Ageing in Place

Researchers from the Infertility and Reproduction Program at Hunter Medical Research Institute have unearthed a connection between lipid peroxidation that occurs in both poor sperm health and in other diseases.

The University of Newcastle has launched a third Doctoral Training Centre (DTC) in Energy.

The Hunter Medical Research Institute (HMRI), Hunter New England Health Local Health District (HNELHD), the Hunter New England Central Coast Primary Health Network (HNECCPHN) and the University of Newcastle are improving access to diabetes care in rural and regional areas.

The Australian Research Council (ARC) has announced its latest rounds of funding for the Future Fellowships and DECRA schemes, with four University of Newcastle projects attracting funding of more than $3 million for projects of national importance.

More than half of Australian employees feel lonely in their work, with 15 per cent feeling 'extremely lonely', and younger Australians below 29 years of age feeling lonelier than any other age group.

HMRI and University of Newcastle researchers have discovered that treating patients who have late-stage treatment resistant melanoma with a combination of two existing drugs significantly increases their survival times.

The COVID-19 pandemic has increased rates of depression and anxiety in Australia by 24-28 per cent, placing significant resource pressures on its health systems.